The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2023 | Clinical requirements for managing immune-related adverse events
Yinghong Wang, MD, PhD, MS, The University of Texas MD Anderson Cancer Center, Houston, TX, provides an overview of factors clinicians should consider when treating immune-related adverse events in patients with gastrointestinal cancers. Familiarity of the specific disease, as well as knowledge of available treatment options and long-term outcomes are necessary to improve the quality of care patients can receive. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
